Skip to main content
Clinical Trials/JPRN-UMIN000031976
JPRN-UMIN000031976
Completed
未知

Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease - To explore genome biomarkers for Tolvaptan efficacy in ADPKD

Otsuka Pharmaceutical Co.,Ltd.0 sites890 target enrollmentMarch 29, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Autosomal Dominant Polycystic Kidney Disease
Sponsor
Otsuka Pharmaceutical Co.,Ltd.
Enrollment
890
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2018
End Date
March 30, 2019
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who did not participate in extension Trial(Refer to ClinicalTrials.gov:NCT01280721 or NCT01214421\)

Outcomes

Primary Outcomes

Not specified

Similar Trials